North East and North Cumbria
ICS Formulary
6 Endocrine system
06-07-01 Bromocriptine and other dopaminergic drugs
Bromocriptine 2.5mg tablets
Formulary
MHRA Drug Safety Update (October 2024): Bromocriptine: monitor blood pressure when prescribing bromocriptine for prevention or inhibition of post-partum physiological lactation
Cabergoline 500microgram and 1mg tablets
Formulary
Quinagolide
Formulary
Links
MHRA Drug Safety Update (October 2024): Bromocriptine: monitor blood pressure when prescribing bromocriptine for prevention or inhibition of post-partum physiological lactation
NICE HST21: Setmelanotide for treating obesity caused by LEPR or POMC deficiency
NICE HST31: Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome
NTAG Endocrine System Recommendations
Key
Full Site